Company
Cardio Diagnostics Holdings, Inc. (CDIO)
Standardized SEC financial data for Cardio Diagnostics Holdings, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001870144 · NASDAQ · In Vitro & In Vivo Diagnostic Substances.
Revenue growth (YoY)
-57.5%
Return on equity
-93.2%
Free cash flow
-$5.9M
Current ratio
9.79×
EPS (diluted)
$-3.71
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $901 | $950 | $17K | $35K | $15K |
| R&D expense | $31K | $40K |
Balance sheet
| USD | FY2023 | FY2024 | FY2024 | FY2025 | FY2025 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.3M | — | $7.8M | — | — | $5.1M |
| Accounts receivable |
Get CDIO data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/CDIO/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/CDIO/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"